Northpointe Capital’s Genocea Biosciences, Inc. GNCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-98,329
| Closed | -$912K | – | 205 |
|
|
2017
Q4 | $912K | Sell |
98,329
-4,618
| -4% | -$42.8K | 0.1% | 163 |
|
|
2017
Q3 | $1.2M | Sell |
102,947
-64,061
| -38% | -$748K | 0.13% | 162 |
|
|
2017
Q2 | $6.97M | Buy |
167,008
+14,672
| +10% | +$613K | 0.73% | 50 |
|
|
2017
Q1 | $7.42M | Sell |
152,336
-22,136
| -13% | -$1.08M | 0.81% | 40 |
|
|
2016
Q4 | $5.75M | Sell |
174,472
-5,314
| -3% | -$175K | 0.57% | 63 |
|
|
2016
Q3 | $7.36M | Buy |
179,786
+85,284
| +90% | +$3.49M | 0.76% | 44 |
|
|
2016
Q2 | $3.1M | Sell |
94,502
-25,201
| -21% | -$827K | 0.37% | 95 |
|
|
2016
Q1 | $7.41M | Buy |
119,703
+69,727
| +140% | +$4.32M | 0.92% | 30 |
|
|
2015
Q4 | $2.74M | Hold |
49,976
| – | – | 0.36% | 107 |
|
|
2015
Q3 | $2.74M | Buy |
+49,976
| New | +$2.74M | 0.36% | 108 |
|